MIT develops nano 'protein factories'; RNA molecules show signs of halting head and neck cancer;

> Protein-based drugs sometimes struggle to reach their targets after bodily fluids degrade their casings. In response, MIT has developed a nanoparticle that can synthesize proteins on demand using materials from the body. Story

> Researchers at the California Institute of Technology have developed a nanoparticle that delivers siRNA and has shown promise in treating head and neck cancer in animal testing. Article

> Israel's Ben-Gurion University has licensed its V-Smart drug delivery platform to New York's Lauren Sciences, which will use it to develop treatments for central nervous system disorders. News

> Scientists at Rice University may have found a new way to get drugs directly into cancer cells using light-harvesting nanoparticles to transform laser energy into "nanobubbles." Rice University release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.